| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 919 | 784 | +17.2% |
| EBITDA | 8.9 | 1.4 | +547.8% |
| EBITDA margin | 1.0% | 0.2% | +0.8 pts |
| Profit before tax | −18.3 | −33.0 | — |
| Net profit | 36.8 | −22.0 | — |
| EPS | ₹5.59 | −₹3.31 | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 |
|---|
| 838 | — | — | — | — | |
| 8.7 | 8.7 | 8.9 | 6.0 | 104 | |
| 1,054 | 1,054 | 1,152 | 1,047 | 803 | |
| 1,884 | — | — | — | — | |
| 3,268 | 3,133 | 2,693 | 2,394 | 2,654 | |
| — | +16.4% | +12.5% | −9.8% | — | |
| 138 | 131 | 135 | 136 | 205 | |
| 4.2% | 4.2% | 5.0% | 5.7% | 7.7% | |
| 81.0 | 72.1 | 80.9 | 87.0 | 164 | |
| 84.0 | 25.2 | 14.7 | 46.5 | 111 | |
| 2.6% | 0.8% | 0.6% | 1.9% | 4.2% | |
| ₹12.65 | ₹3.79 | ₹2.52 | ₹7.00 | ₹16.73 | |
| — | +50.6% | −64.0% | −58.2% | — | |
| — | 220 | 130 | −101 | 355 | |
| — | −44.4 | −146 | −171 | −210 | |
| 176 | 176 | −16.2 | −272 | 145 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 838.0 | |
| - Cash, Equiv & ST Investments | 104.1 | 6.0 | 8.9 | 8.7 | 8.7 | |
| + Total Debt | 803.3 | 1,046.8 | 1,152.3 | 1,054.2 | 1,054.2 | |
| Enterprise Value | — | — | — | — | 1,883.5 | |
| Revenue | 2,654.4 | 2,394.4 | 2,693.0 | 3,133.4 | 3,268.3 | |
| Growth %, YoY | — | -9.8 | +12.5 | +16.4 | — | |
| EBITDA | 204.7 | 136.4 | 134.8 | 130.9 | 138.4 | |
| Margin % | 7.71 | 5.70 | 5.01 | 4.18 | 4.24 | |
| EBIT | 164.2 | 87.0 | 80.9 | 72.1 | 81.0 | |
| Net Income | 111.1 | 46.5 | 14.7 | 25.2 | 84.0 | |
| Margin % | 4.19 | 1.94 | 0.55 | 0.80 | 2.57 | |
| EPS, Adj (current shares) | 16.73 | 7.00 | 2.52 | 3.79 | 12.65 | |
| Growth %, YoY | — | -58.2 | -64.0 | +50.6 | — | |
| Cash from Operations | 354.7 | -101.3 | 129.6 | 219.9 | — | |
| Capital Expenditures | -209.9 | -170.7 | -145.7 | -44.4 | — | |
| Free Cash Flow | 144.8 | -272.0 | -16.2 | 175.5 | 175.5 | |
Prices at the previous close · figures from the company's filings with NSE
Dhampur Bio Organics (NSE: DBOL) had a market capitalisation of ₹838 crore at the previous close (₹126.23 a share), a PE ratio of 10.0 on the last four quarters' profit and a price-to-book ratio of 0.82. In FY26 its consolidated net profit was ₹25.2 crore on revenue of ₹3,133 crore; in Q1 FY27 (April–June 2026) it was ₹36.8 crore. Its debt-to-equity ratio was 1.03 on 31 March 2026. Promoters held 51.00% of the shares on 30 September 2026.
Dhampur Bio Organics' PE ratio is 10.0 at the previous close (₹126.23 a share): a market capitalisation of ₹838 crore divided by consolidated net profit of ₹84 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹25.2 crore) it is 33.3.
Dhampur Bio Organics' price-to-book (PB) ratio is 0.82 at the previous close: a market capitalisation of ₹838 crore divided by shareholders' equity (book value) of ₹1,027 crore on 31 March 2026. That is a book value of ₹154.64 per share against a share price of ₹126.23.
Dhampur Bio Organics' debt-to-equity ratio was 1.03 on 31 March 2026: borrowings of ₹1,054 crore against total equity of ₹1,027 crore. A year earlier, on 31 March 2025, it was 1.14.
Dhampur Bio Organics' market capitalisation was ₹838 crore at the previous close: 6.64 crore shares at ₹126.23 each.
No. Dhampur Bio Organics had borrowings of ₹1,054 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 1.03. Its cash and current investments were ₹36.2 crore, so its net debt was ₹1,018 crore.
In 2026, Dhampur Bio Organics has declared one dividend: ₹1.50 with record date 17 July 2026.
Dhampur Bio Organics' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,027 crore on 31 March 2026, up 1.5% from ₹1,012 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹838 crore at the previous close.
Dhampur Bio Organics' book value per share was ₹154.64 on 31 March 2026: shareholders' equity of ₹1,027 crore divided by the 6.64 crore shares in issue. The share price at the previous close was ₹126.23.
Dhampur Bio Organics' basic earnings per share (EPS) were ₹3.81 in FY26, against ₹2.21 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹12.75.
In FY26, Dhampur Bio Organics' return on equity (ROE) was 2.5% and its return on capital employed (ROCE) was 5.5%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 1.7% and ROCE 6.3%.
Dhampur Bio Organics' dividend yield is 1.19% at the previous close: dividends of ₹1.50 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹126.23. They were ₹1.50 on 17 July 2026.
Promoters held 51.00% of Dhampur Bio Organics on 30 September 2026, up 0.22 percentage points from 50.78% the previous quarter and up 0.35 percentage points from 50.65% a year earlier, according to the shareholding pattern filed with NSE.
On 30 September 2026, Dhampur Bio Organics' shares were held by promoters 51.00%, foreign portfolio investors (FII/FPI) 0.55%, domestic institutions (DII) 0.37% (including mutual funds at 0.00%) and retail and other non-institutional investors 46.91%. Over the year, FII holding was up 0.20 percentage points from 0.35% and DII holding was down 0.08 percentage points from 0.45%.
In FY26, Dhampur Bio Organics generated ₹220 crore of cash from operations and spent ₹44.4 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹176 crore. In FY25 it was −₹16.2 crore.
In FY26, Dhampur Bio Organics earned net profit of ₹25.2 crore on revenue of ₹3,133 crore, against ₹63.5 crore on ₹1,245 crore for Magadh Sugar & Energy. Dhampur Bio Organics' operating margin was 2.3% (Magadh Sugar & Energy 9.4%) and its return on equity 2.5% (Magadh Sugar & Energy 7.4%).
Dhampur Bio Organics' latest results are for Q1 FY27 (April–June 2026), filed on 14 July 2026: consolidated net profit ₹36.8 crore, against a loss of ₹22 crore in Q1 FY26; revenue from operations ₹919 crore, up 17.2% year on year.
In FY26 (April 2025–March 2026), Dhampur Bio Organics' consolidated net profit was ₹25.2 crore, up 50.6% from ₹16.7 crore in FY25, on revenue from operations of ₹3,133 crore (up 16.4%). Over three years, from FY23, net profit was down 77.3%.
Dhampur Bio Organics has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
On FY26 consolidated figures, against Magadh Sugar & Energy, ZUARI INDUSTRIES and Dwarikesh Sugar Industries: Dhampur Bio Organics' operating margin of 2.3% is the lowest of the four (Magadh Sugar & Energy 9.4%, ZUARI INDUSTRIES 3.9%, Dwarikesh Sugar Industries 3.6%; peer average 5.6%); its return on equity of 2.5% is the lowest of the four (Magadh Sugar & Energy 7.4%, ZUARI INDUSTRIES 2.5%, Dwarikesh Sugar Industries 3.8%; peer average 4.6%); its revenue growth over three years of 5.7% a year is the second highest of the four (Magadh Sugar & Energy 9.3% a year, ZUARI INDUSTRIES 3.0% a year, Dwarikesh Sugar Industries −12.6% a year; peer average −0.1% a year).
From Dhampur Bio Organics' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.